startup.bid
EN
EnglishEspañolPortuguêsFrançaisDeutschItalianoNederlandsSvenskaDanskNorskPolskiSlovenščinaTürkçeРусскийBahasa IndonesiaBahasa MelayuFilipinoTiếng ViệtKiswahiliहिन्दीاردوالعربيةעברית日本語한국어中文繁體中文

Forcyte Biotechnologies

Discover drugs that control how much cells "squeeze" to treat disease

Shut down

About

In a nutshell: many diseases are caused by how much your cells squeeze (asthma, fibrosis, others). We discover drugs that control how much cells squeeze, with ease, to treat disease.

We use patented bioMEMS technology to turn cell strength (cells' ability to pull/ squeeze) into a quantifiable metric in drug discovery, to help find better drugs for mechanical diseases.

We screen 100,000s of drugs against numerous contractile human cell types to comprehensively map human mechanobiology (the "contractome") and identify promising drug development starting points to deliver novel medicines to treat mechanically-driven diseases including asthma, hypertension, preterm labor, fibrosis, and others.

Topics

Location
Los Angeles, CA, United States
Team size
5 employees
YC batch
Winter 2021
Status
Shut down
Stage
Early stage

Similar startups & competitors

Questions and answers

What does Forcyte Biotechnologies do?

Discover drugs that control how much cells "squeeze" to treat disease

Where is Forcyte Biotechnologies based?

Los Angeles, CA, United States

How many people work at Forcyte Biotechnologies?

5 employees, according to the company profile.

Has Forcyte Biotechnologies raised money?

There are no funding rounds for Forcyte Biotechnologies in our data.

What are the alternatives to Forcyte Biotechnologies?

Similar startups: Oncobox, Biocartesian, and Relevium Medical.